Diaceutics PLC (LON:DXRX) Stock Rockets 29% But Many Are Still Ignoring The Company
May 30
U.K. (FTSE) Life Sciences Industry Analysis
UpdatedJun 02, 2024
DataAggregated Company Financials
Companies9
- 7D-1.1%
- 3M-8.4%
- 1Y-45.7%
- YTD-34.0%
Over the last 7 days, the Life Sciences industry has dropped 1.1%, driven by a pullback from Oxford Nanopore Technologies of 2.7%. However, the industry is down 46% over the past year. As for the next few years, earnings are expected to grow by 16% per annum.
Industry Valuation and Performance
Has the U.K. Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 02 Jun 2024 | UK£1.6b | UK£295.6m | -UK£189,808,553.55 | 11.3x | -8.6x | 5.5x |
| Tue, 30 Apr 2024 | UK£1.5b | UK£292.8m | -UK£188,866,378.07 | 7254.8x | -8x | 5.2x |
| Thu, 28 Mar 2024 | UK£1.8b | UK£295.9m | -UK£213,188,106.13 | 7353.3x | -8.4x | 6.1x |
| Sat, 24 Feb 2024 | UK£1.9b | UK£285.8m | -UK£189,209,049.14 | 6964.3x | -10.3x | 6.8x |
| Mon, 22 Jan 2024 | UK£2.9b | UK£450.2m | -UK£176,590,140.00 | 62.1x | -16.2x | 6.4x |
| Wed, 20 Dec 2023 | UK£3.1b | UK£449.9m | -UK£173,918,274.00 | 52.7x | -17.9x | 6.9x |
| Fri, 17 Nov 2023 | UK£3.0b | UK£455.8m | -UK£168,936,857.00 | 50.3x | -18x | 6.7x |
| Sun, 15 Oct 2023 | UK£2.9b | UK£458.7m | -UK£165,688,739.00 | 51.1x | -17.6x | 6.3x |
| Tue, 12 Sep 2023 | UK£3.1b | UK£440.3m | -UK£166,835,037.00 | 67.5x | -18.6x | 7x |
| Thu, 10 Aug 2023 | UK£3.4b | UK£476.6m | -UK£124,757,538.00 | 70.6x | -27.5x | 7.2x |
| Sat, 08 Jul 2023 | UK£2.9b | UK£476.3m | -UK£124,525,700.00 | 66.1x | -23.4x | 6.1x |
| Mon, 05 Jun 2023 | UK£3.3b | UK£477.0m | -UK£116,998,754.00 | 67.8x | -28.5x | 7x |
| Wed, 03 May 2023 | UK£3.2b | UK£480.2m | -UK£117,304,256.00 | 36.7x | -26.9x | 6.6x |
| Fri, 31 Mar 2023 | UK£2.9b | UK£458.9m | -UK£119,106,015.00 | 34.4x | -24.6x | 6.4x |
| Sun, 26 Feb 2023 | UK£3.1b | UK£444.0m | -UK£183,285,157.00 | 43.7x | -17x | 7x |
| Tue, 24 Jan 2023 | UK£3.4b | UK£442.8m | -UK£182,525,028.00 | 49.5x | -18.9x | 7.8x |
| Thu, 22 Dec 2022 | UK£3.4b | UK£443.6m | -UK£182,997,271.00 | 49.4x | -18.6x | 7.7x |
| Sat, 19 Nov 2022 | UK£3.6b | UK£447.5m | -UK£178,669,556.00 | 50x | -20.3x | 8.1x |
| Mon, 17 Oct 2022 | UK£3.5b | UK£449.2m | -UK£176,568,208.00 | 42.7x | -19.8x | 7.8x |
| Wed, 14 Sep 2022 | UK£3.7b | UK£365.6m | -UK£190,965,855.00 | 48.9x | -19.5x | 10.2x |
| Fri, 12 Aug 2022 | UK£4.1b | UK£368.3m | -UK£191,079,051.00 | 49.2x | -21.7x | 11.2x |
| Sun, 10 Jul 2022 | UK£3.9b | UK£366.7m | -UK£188,130,827.00 | 39.8x | -20.5x | 10.5x |
| Tue, 07 Jun 2022 | UK£4.0b | UK£360.3m | -UK£192,170,833.00 | 41.9x | -21x | 11.2x |
| Thu, 05 May 2022 | UK£4.9b | UK£922.8m | -UK£165,801,060.00 | 42.7x | -29.4x | 5.3x |
| Sat, 02 Apr 2022 | UK£6.6b | UK£929.7m | -UK£311,745,820.00 | 47.5x | -21.2x | 7.1x |
| Mon, 28 Feb 2022 | UK£7.1b | UK£891.2m | -UK£199,059,728.00 | 43.5x | -35.8x | 8x |
| Wed, 26 Jan 2022 | UK£7.4b | UK£849.2m | -UK£185,312,425.00 | 30.3x | -39.9x | 8.7x |
| Fri, 24 Dec 2021 | UK£9.7b | UK£849.4m | -UK£186,332,023.00 | 30.7x | -52.3x | 11.5x |
| Sun, 21 Nov 2021 | UK£9.5b | UK£843.7m | -UK£189,346,742.00 | 20.8x | -50.3x | 11.3x |
| Tue, 19 Oct 2021 | UK£7.9b | UK£819.7m | -UK£188,892,839.00 | 30.9x | -41.8x | 9.6x |
| Thu, 16 Sep 2021 | UK£3.0b | UK£674.8m | -UK£136,626,800.35 | 27.6x | -21.8x | 4.4x |
| Sat, 14 Aug 2021 | UK£2.9b | UK£670.4m | -UK£160,499,800.35 | 64.1x | -18.3x | 4.4x |
| Wed, 09 Jun 2021 | UK£3.6b | UK£670.8m | -UK£88,500,847.08 | 74.8x | -40.4x | 5.3x |
Price to Earnings Ratio
-40.4x
Current Industry PE
- Investors are pessimistic on the British Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 8.6x is higher than the industry's current PS ratio of 5.5x.
Past Earnings Growth
- The earnings for companies in the Life Sciences industry have deteriorated over the last three years.
- Revenues have also declined 24% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Trends
Which industries have driven the changes within the U.K. Healthcare industry?
| GB Market | -0.56% | |
| Healthcare | -0.64% | |
| Life Sciences | -1.10% | |
| Clinical Research and Equipment | -1.10% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ERGO Ergomed | UK£13.46 | 0.1% +UK£14.7m | 3.5% | PE46.7x | |
| C4XD C4X Discovery Holdings | UK£0.12 | 45.9% +UK£9.5m | -16.4% | PE2.9x | |
| MXCT MaxCyte | UK£3.70 | 1.4% +UK£5.2m | 12.1% | PS11.2x | |
| DXRX Diaceutics | UK£1.33 | 3.9% +UK£4.2m | 64.6% | PS4.7x | |
| GDR genedrive | UK£0.015 | -20.3% UK£2.8m | -92.8% | PS29.5x |
